These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1519522)

  • 1. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.
    Assmann G; Schulte H
    Am J Cardiol; 1992 Sep; 70(7):733-7. PubMed ID: 1519522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study.
    Assmann G; Schulte H
    Am J Cardiol; 1992 Dec; 70(19):10H-13H. PubMed ID: 1466311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.
    Assmann G; Schulte H; von Eckardstein A; Huang Y
    Atherosclerosis; 1996 Jul; 124 Suppl():S11-20. PubMed ID: 8831911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of individuals at high risk for myocardial infarction.
    Assmann G; Schulte H
    Atherosclerosis; 1994 Oct; 110 Suppl():S11-21. PubMed ID: 7857378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study.
    Assmann G; Schulte H
    Eur J Epidemiol; 1992 May; 8 Suppl 1():99-103. PubMed ID: 1505660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.
    Assmann G; Schulte H; von Eckardstein A
    Am J Cardiol; 1996 Jun; 77(14):1179-84. PubMed ID: 8651092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).
    Goldbourt U; Behar S; Reicher-Reiss H; Agmon J; Kaplinsky E; Graff E; Kishon Y; Caspi A; Weisbort J; Mandelzweig L
    Am J Cardiol; 1993 Apr; 71(11):909-15. PubMed ID: 8465780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.
    Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
    J Am Heart Assoc; 2024 Jul; 13(14):e034763. PubMed ID: 38958152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia: risks and perspectives.
    Gotto AM
    Am J Cardiol; 1992 Dec; 70(19):19H-25H. PubMed ID: 1466313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
    Rubins HB; Robins SJ; Iwane MK; Boden WE; Elam MB; Fye CL; Gordon DJ; Schaefer EJ; Schectman G; Wittes JT
    Am J Cardiol; 1993 Jan; 71(1):45-52. PubMed ID: 8420235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and classical risk factors--the Münster heart study (PROCAM).
    Assmann G; Schulte H; Cullen P
    Eur J Med Res; 1997 Jun; 2(6):237-42. PubMed ID: 9182651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein cholesterol in coronary artery disease: when higher means later.
    Sbrana F; Puntoni M; Bigazzi F; Landi P; Sampietro T; Rossi G; Rovai D
    J Atheroscler Thromb; 2013; 20(1):23-31. PubMed ID: 22878704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
    Yang SH; Du Y; Li XL; Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    Am J Med Sci; 2017 Aug; 354(2):117-124. PubMed ID: 28864368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
    Heinrich J; Balleisen L; Schulte H; Assmann G; van de Loo J
    Arterioscler Thromb; 1994 Jan; 14(1):54-9. PubMed ID: 8274478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.